Celebrating partnership
The future of brain health depends on the research we invest in today. As people are living longer lives, understanding, preventing, and treating neurodegenerative diseases, like Alzheimer’s, becomes more urgent — and more possible.
Brain Canada has proudly partnered with the Alzheimer’s Association for the last decade, working together to advance cutting-edge research. Through this collaboration, we have supported researchers across Canada through programs such as the Alzheimer’s Association International Research Grant Program (IRGP), and the Advancing Research on Care & Outcome Measurement (ARCOM). In more recent years, we have funded projects exploring a wide range of important areas, including early diagnosis, disease mechanisms, caregiving strategies, and potential new therapies.
These achievements are the result of Brain Canada’s ongoing commitment to advancing brain health research, and of our strong partnership with the Alzheimer’s Association.
We are excited to share that this important work will continue. Brain Canada plans to support the upcoming awards set to launch in July as part of the Alzheimer’s Association International Research Grant Program. Together through continued collaboration and investment, we can drive progress and bring hope to those impacted by Alzheimer’s disease.
Some of the outstanding projects funded through our partnership include:
2022 Alzheimer’s Association IRGP
A Drug Screening Assay to Reduce LINGO-1 Amounts in Neurons
Brian Chen, The Research Institute of the McGill University Health Centre
2023 Alzheimer’s Association IRGP
Self-disclosure about dementia on social media: evidence-informed guidance
Julie Robillard, University of British Columbia
Targeting KCC2 for rescuing functional impairments in Alzheimer’s disease
Majid Mohajerani, Douglas Research Center
Examining vascular risk and menopausal age on women’s increased risk for AD
Jennifer Rabin, Sunnybrook Research Institute
Apolipoprotein receptor 2 in AD-related brain vessel dysfunction
Milène Vandal, University of Calgary
ARCOM 3.0
Measuring and Improving the Quality of Community-Based Dementia Care
Dallas Seitz, University of Calgary
2024 Alzheimer’s Association IRGP
Dynamic interplay of vascular injury and inflammation on AD progression
Julie Ottoy, Sunnybrook Research Institute
Functional connectivity-guided rTMS for personalized treatment of apathy
Shankar Tumati, Sunnybrook Research Institute
Stephen Choi, Sunnybrook Research Institute
Myelin loss and cognitive impairment following SARS-CoV-2 infection
Narlon Cassio Boa Sorte Silva, Concordia University